Mental Health

Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.

On February 6, 2023, Pharmacy Times also learned that the FDA just accepted a new drug application (NDA) for this treatment.

Data show pharmacist-led clinical consultations can improve patient adherence to medication plans.

The economic burden of symptoms of major depressive disorder were estimated to cost $326 billion for the United States in 2018 alone.

Tracey McGrath, PharmD, pharmacy manager at Sam’s Club, shares strategies to continue exploring art and play as an adult with a busy professional life to help maintain mental and emotional wellbeing.

This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.

Alcohol-related disorders were the most expensive substance type that contributed to total estimated medical cost.

Relatively higher suicide risks were observed for cancer types with a poor prognosis and high symptom burden in the first 2 years after diagnosis.

In younger children, emotional maltreatment led primarily to behavioral problems, whereas in older children it was more likely to lead to depression and anxiety disorders.

Study highlights the impact of individual expectations for positive and negative outcomes.

Patients on an SSRI were reportedly less likely to use positive or negative feedback to guide learning.

The findings suggest that reduced gray matter is not the cause of psychiatric illness, although it is found in regions of the brain associated with it.

A recent study shows that heart patients who learn to cope with stress in group therapy are nearly 2 times less anxious and depressed.

Researchers noted no significant changes in anxiety or depression between patients who were positive or negative for amyloid deposition.

Pharmacists can use behavioral and natural tools to assist patients suffering from chronic, daily stressors and other ailments.

There is a lack of funding for attention-deficit hyperactivity disorder and coinciding psychological research compared to the funds generated for autism research.

Research highlights that 6 doses of sublingual ketamine may be more effective than 3 doses, however both can ameliorate symptoms of anxiety and depression.

Study notes that evaluating changes in the proportion of hospitalizations for mental health conditions among adolescents is vital to ensure the prioritization of public health programs that address psychiatric health care needs that emerged during the COVID-19 pandemic.

The atypical antipsychotic is an extended-release injectable suspension that is administered bi-weekly.

Clonidine works on adrenergic receptors in the brain, which are known for their role in fight-or-flight responses and are believed to be activated in post-traumatic stress disorder.

Jordan Sloshower, MD, MSc, explains his experience working in several clinical trials investigating psilocybin-assisted therapy.

Analysis focuses on causal effects while accounting for other environmental and genetic factors, such as a family history and socioeconomic disadvantages.

Joseph Araujo, Chief Scientific Officer at Mindset Pharma, sat down to discuss natural vs. synthetic psychedelics.

Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.

Individuals in metropolitan counties used mental health services more than individuals in rural counties.

Pharmacists are ideally positioned within communities to identify patients struggling with perinatal depression.

The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.

First direct evidence of diminished 5-HT release proves hypothesis, according to a new analysis published in Biological Psychiatry.

Cariprazine (Vraylar; AbbVie, Gedeon Richter) is indicated as an adjunctive therapy to antidepressants for treating adult patients with major depressive disorder.

Although the evidence suggested some deterioration for a few aspects of mental health, the overall findings were mixed with no clear pattern.